About Us

John Schembri

John Schembri is Vice President, Finance and Controller at Akero Therapeutics and leads all financial operations and accounting for the company. Prior to Akero Therapeutics, John worked for many successful emerging biotechnology companies, including Global Blood Therapeutics, BiPar Sciences and Sirna Therapeutics, among others. At these companies, he closed multiple public and private equity and debt financings and helped sell three commercial and clinical-stage biotechnology companies for over $3.6 billion. He holds a BA from California Polytechnic State University, San Luis Obispo and is a Certified Equity Professional from Santa Clara University.

© 2019 Akero Therapeutics, Inc. All rights reserved. Terms of Use.